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Purpose: Photodynamic therapy (PDT) has been demonstrated to inhibit experimental 
intimal hyperplasia nd to lead to expedient reendothelialization but negligible repopu- 
lation of  the vessel media. The mechanism that underlies the differential ingrowth of  cells 
into PDT-treated vessel segments is not tmderstood. Because the extraceUular matrix 
(ECM) is known to modulate specific ell functions, this study was designed to determine 
whether PDT of  isolated ECM affects the function of  endothelial cells (ECs) and smooth 
muscle cells (SMCs). 
Methods: PDT of  bovine aortic EC-ECM was performed with chloroaluminum sulfonated 
phthalocyanine and 675-nm laser light. Control specimens included untreated ECM, 
ECM-free plates, and ECM exposed to either l ight or photosensitizer only. Cell function 
was characterized by attachment, proliferation, and migration of  ECs or SMCs that were 
plated onto identically treated matrixes. 
Results: SMC attachment (86% + 0.4% vs 95% +-0.4%), proliferation (46% + 0.5% vs 
100% + 1.4%), and migration (40% • 1.0% vs 100% + 0.9%) were significantly inhibited 
after PDT of  ECM when compared with untreated ECM (all p < 0.001). In contrast, PDT 
of  ECM significantly enhanced EC proliferation (129% + 6.2% vs 100% • 6.2%; p < 0.03) 
and migration (118% + 1.2% vs 100% • 0.8; p < 0.01), but did not affect attachment. 
Conclusions: This report  establishes PDT-induced changes in the ECM with a result of  
inhibition of  SMCs and stimulation of  EC functions. I t  provides insight into how 
PDT-treated arteries can develop favorable EC repopulation without SMC-derived intimal 
hyperplasia. These findings may help provide a better understanding of the interactions 
between cells and their immediate nvironment in vascular emodeling. (J VASC SURG 
1996;23:698-705.) 
From the Division of Vascular Surgery and the Wellman Labora- 
tories of Photomedicine, Massachusetts General Hospital, Har- 
vard Medical School; and the Division of Vascular Surgery, 
Boston Veterans Administration Medical Center, Boston Uni- 
versity School of Medicine (Dr. Watkins); Boston. 
Supported inpart by NIH grants HL 02583 and HL 48152, and 
ONR contract N00014-91-C-0084. Dr. Adili received a fellow- 
ship grant from the Deutsche Forschungsgemeinschaft (Ad 
106/2-1). Dr. van Eps receivcd agrant f?om the Dutch Heart 
Association (R94138). Dr. Karp, as a Harvard medical student, 
was the recipient of a 1994 SVS-ISCVS student research fellow- 
ship provided by the Lifeline Foundation. 
Presented in part as a poster at the Annual Joint Meeting of the 
Society for Vascular Surgery and the International Society tbr 
Cardiovascular Surgery, North American Chapter, New Orleans, 
La., June 11-14, 1995. 
Reprint requests: Glenn M. LaMuraglia, MD, Division of Vascular 
Surgery, Massachusetts General Hospital, Boston, MA 02114. 
Copyright 9 1996 by The Society for Vascular Surgery and 
International Society for Cardiovascular Surgery, North Ameri 
can Chapter. 
0741-5214/96/$5.00 +  24/1/71031 
698 
Intimal hyperplasia ( IH)  is one o f  the most im- 
portant  obstacles to satisfactory long-term patency 
after invasive vascular procedures. Shortly after injury 
to the b lood vessel wall, smooth muscle cells (SMCs) 
fi, om the media begin migrat ing to and prol i fcrating 
in thc subendothel imn,  where significant quantities of  
cxtracellular connective tissue matrix are subsc 
qucntly deposited. ~,2 The endpoint  o f  this pathologic 
response to vascular injury is thc stcnotic lesion, 
which may ult imately lead to vascular occlusion. 
Efficient control  o f  IH  is currently the subject of  
many experimental nd clinical trials, but to date no 
effective therapeutic regimen has been developed that 
will ult imately prevent his process from occurr ing in 
humans. Many studies have used a wide array of  
pharmacologic compounds,  but although they add to 
an understanding o f  the pathobio logy o f  the IH  
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disorder, most have failed to translate into clinically 
effective therapy. 3 Therefore, numerous alternate 
methods are currently being investigated. 
One such method is photodynamic therapy 
(PDT), which has been used successfully to inhibit 
experimental IH.4 To perform PDT, a photosensitizer 
dye is administered, and the area of interest is irradi- 
ated with wavelength-specific light. Absorption of 
light by the dye leads to the generation offi'ee radicals, 
which are believed to exert cytotoxic effects by 
inducing lipid peroxidation in cellular membranes 
and organelles. "~'' Targeting of the cells in the arterial 
wall is possible because of elevated photosensitizer 
concentrations and characteristic partitioning of the 
drug in intimal hyperplastic tissue. 7PDT of arteries 
and vein grafts has been demonstrated to entirely 
eradicate cells from the vascular wall and to inhibit the 
development of IH. 4,8 This eftkct, however, is not 
accompanied by thrombosis, tructural deterioration 
of the artery wall, or myointimal proliferation, as 
noted after thermal injury or gamma irradiation. 9 ~ 
Despite total cell eradication immediately after the 
treatment, histologic examination of arteries sub- 
jected to PDT reveals a good healing response with 
complete reendothelialization and almost no medial 
repopulation. 4 These findings cannot be explained by 
mere free radical-induced cytotoxicity. Complex in- 
teractions between cells and extracellular matrix 
(ECM) proteins are thought o be responsible for the 
modeling of the arterial wall and other tissues. 12''3 
Because the extracellular environment is known to 
modulate specific cell functions, this in-vitro study 
was devised to ascertain whether PDT of isolated 
ECM affects the physiology of vascular endothelial 
cells (ECs) and SMCs. 
MATERIALS AND METHODS 
Primary bovine aortic SMC and EC cultures were 
established from aortas of freshly slaughtered calves. 
ECs were obtained by scraping the intimal aortic 
surface and dispersion in 0.1% CLS II collagenase 
(Worthington; Freehold, N.J.). The EC identity was 
confirmed by the polygonal, monolayer shape seen on 
phase-contrast microscopy and by uptake of the 
fluorescent probe Di-I-Ac-LDL (Biomedical Re- 
search Technologies, Inc.; Stoughton, Mass.). SMC 
cultures were established with the explant echnique 
from strips of aortic media. ~4 Their identity was 
verified by indirect immunofluorescence with an 
anti-{* actin antibody (Biomedical Research Tech- 
nologies). Both cell types were kept in a 37 ~ C 
incubator in the presence of 5% CO 2 and were ted 
every 48 to 72 hours with eompletc Dulbeeeo's 
Modified Eagles Media supplemented with 10% calf 
serum, 100 U/ml  penicillin, 100 btg/ml streptomy- 
cin, and 0.6 mol /L  L-glutamine (Gibco; Grand 
Island, N.Y.). Cells were passed at a ratio of 1:5 using 
0.05% trypsin/0.125% ethylenediamine t traacetic 
acid upon reaching confluence and used during pas- 
sages 2 through 6. 
Preparation of  ECM. ECs were subcultured in 
six-well plates (Falcon, Becton Dickinson; Lincoln 
Park, N.J.) and left confluent for 8 to 10 days. For 
isolation of the ECM, the cell monolayer was removed 
after 30 minutes of incubation in phosphate-buffered 
saline solution (PBS) containing 0.5% Triton X-100 
(Sigma Chemical; St. Louis) and 20 mmol /L  
NH4OH , and after three rinses with PBS) 5 These 
steps were carefully monitored by phase-contrast 
microscopy. The resultant ECM that coated the 
cell-culture plates was covered with 1.5 ml PBS and 
stored at 4 ~ C tbr use within 48 hours. 
The presence of ECM was verified by scanning 
electron microscopy. One sterile 13 ram-round plas- 
tic coverslip (Nunc, Inc.; Naperville, Ill.) was placed 
in each well, and ECM was prepared as described 
above. After removal of the cells, the covcrslips were 
transferred into 4% glutaraldehyde in 0.1 mol /L  cac 
odylate buffer and incubated for 1 hour. After dehy- 
dration in a graded series of alcohols and rinsing in 
hexamethyldisilazane (El ctron Microscopy Sciences; 
Ft. Washington, Pa.), the specimens were allowed to 
air-dry, were coated with gold-palladium in a cool 
sputter coater, and were examined with an scanning 
electron microscope (Amray 1400, Amray; Bedford, 
Mass.). 
PDT. ECMs were covered with 1.5 ml of the 
photosensitizer drug chloroaluminum sulfonated 
phthalocyaninc (CASPc; CIBA-Geigy; Basel, Swit- 
zerland) in PBS (5 lag/ml)just before irradiation (Fig. 
1) with thermoneutral light (fluence, 100 J/cm2; 
irradiance, 100 mW/cm2; ~, = 675 nm) delivered by 
an argon-pumped dye laser (Coherent Innova I 100 
and Coherent CR 599, Coherent; Palo Alto, Calif.). 
Alter PDT the wells were rinsed three times with PBS, 
covered with aluminum foil to aw)id additional expo- 
sure to ambient light, and stored at 4 ~ C. Control 
specimens included untreated ECM, ECM-free 
plates, and ECM exposed to light irradiation only. To 
assess possible dark-effects of the photosensitizer, 
matrixes were incubated fbr 2 hours with CASPc in 
the absence of light. 
Attachment assay. ECs or SMCs were plated at a 
density of 2 • 10 "~ cells per well. The plates were 
gently agitated to ensure homogeneous dispersion of 
the cells and were incubated for 2 hours at 37 ~ C. The 
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Fig. 1. Experimental setup to irradiate isolated ECM in 
six-well plates with laser light. The six-well plate is moved on 
a light-impervious block with an aperture that provides 
illumination of one well at a time, keeping other wells 
dark. 
unattached cells were gently washed off and trans- 
ferred into isoton (Isoton II, Coulter Corp.; Miami). 
The cell numbers were counted with an electronic ell 
counter (Multisizer, Coulter Electronics Ltd.; Luton, 
United Kingdom), and the percent attachment was 
derived from the number of unattached cells. 
Proliferation assay. SMCs or ECs werc plated at 
a density of 1 x l0 s cells per well. M~er 24 hours of 
incubation in serum-poor (0.5%) media, 1 gCi aH- 
thymidine (New England Nuclear; Boston) was 
added to the cells fbr five hours. Serum-poor media 
was used to ensure that ECM was not subjected to 
serum constituents hat might bind to the ECM and 
elicit potential effects on cellular proliferation. After 
three washes with PBS, 1.5 ml 0.5% trypsin-ethylene- 
diamine tetraacetic acid was added fur at least 30 
minutes. The wells were then vigorously washed, the 
cell count was assessed with a hemocytometer, and the 
radioactivity in each well was quantitated with a 
scintillation counter (Beckman Instruments, Inc.; 
Fullerton, Calif.). The resulting data, expressed as 
counts/cel l /minute, were normalized for untreated 
ECM and reported as the percentage of thymidine 
incorporation. 
Migration assay. For the migration assay, a cir- 
cular metal fence that prevented the cells from leaking 
out after inoculation was placed into the central 
portion of each well. 16 On the first day, 7.5 • 104 cells 
suspended in serum-poor media were seeded into the 
central fence of the dish, where they were constrained 
on an area of 0.62 cm 2. After 4 hours of incubation at 
37 ~ C, the unattached cells were gently removed, and 
fresh media was added. Cell migration was initiated 
after release of contact inhibition by removal of the 
fence. Confluent cell cultures with sharply defined 
circular margins were obtained. The distances be- 
tween the baseline mark and the confluent cell front in 
fuur centrifugal directions were measured aily with a 
calibrated microscope yepiece reticle and averaged. 
The total migration distance after 7 days was reported 
as percent of cell distance migration compared with 
untreated ECM. 
Immunostain ing of  ECM. To verily the strut 
tural integrity of ECM in the cell-culture dishes, 
normal and PDT-trcated ECM were incubated for 1 
hour at room temperature with a mouse anti-human 
fibronectin antibody (Gibco). The secondary anti- 
body was a fluorescein-conjugatcd goat affinity puri- 
fied mouse immunoglobulin G (Cappel; Westchestcr, 
Pa.). Excitation wavelengths between 450 and 490 
nm and an emission band-pass between 515 and 565 
nm were used fbr fluorcsccncc imaging. Fibronectin- 
coated six-well plates served as positive control 
specimens; empty plates served as negative control 
specimens. 
Statistical analysis. All data arc expressed as 
mean + SEM and were analyzed with a one-way 
analysis of variance and Tukey's Honest Significant 
DiffErence post hoc test fbr multiple comparisons 
(Statistica, Statsoft; Tulsa, Okla.). Results were con- 
sidered statistically significant i fp < 0.05. 
RESULTS 
At a magnification of x5000, bovine aortic EC 
ECM appeared as a ubiquitous, fibrillar, and nonho- 
mogeneous network (Fig. 2). The presence of fi 
bronectin, a major constituent of EC-ECM, was 
evaluated with an antibody against he cell-binding 
domain of fibronectin. As demonstrated in Fig. 3, 
untreated ECM yielded a strong fluorescence signal 
after the cells were removed. 
To determine how the presence of this ECM 
would generally affect vascular SMC and EC physiol- 
ogy in our model, SMCs and ECs were plated on 
untreated ECM or directly on cell-culture plastic. The 
attachment of either cell type to ECM did not differ 
from SMC and EC attachment to plastic (Fig. 4). 
SMC proliferation on ECM, however, increased by 
70% and migration increased approximately 85% 
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Fig. 2. Scanning electron micrograph of isolated EC- 
ECM in plastic tissue-culture dish (original magnification, 
x5000). A fibrillar, nonhomogcneous network of ECM 
covers the plastic tissue-culture dish. Bar equals 5 }am. 
when compared with SMCs oil tissue-culture plastic 
( p < 0.001 ; n = 15). Conversely, EC proliferation and 
migration were slightl); but significantly, diminished 
on ECM (p < 0.01; n = 15) when compared with 
plastic (Fig. 4, Table I). 
PDT of  ECM. Immunostaining of ECM with 
antibodies against fibronectin betbre and after PDT 
demonstrated a clearly identifiable three-dimensional 
network with an unchanged fluorescence intensity 
and a similar morphologic pattern, which validated 
the presence of ECM (Fig. 3). Nevertheless, despite 
apparently unchanged fluorescence labeling of the 
cell-binding domain in the fibronectin molecule, 
SMC attachment to PDT-treated ECM was dimin- 
ished by approximately 10% (n= 15; p< 0.005). 
SMC proliferation and migration also decreased 
markedly after PDT (Table I). 
In contrast to SMCs, EC proliferation and migra- 
tion both were significantly potentiated after PDT of 
ECM (p < 0.001 and p < 0.01, respectively; n = 15; 
Table I). EC attachment, however, was unaft~cted. To 
elucidate which, if either, of the two components 
required for PDT (drug and light) was particularly 
relevant for the biologic effects seen after PDT of 
ECM, normal ECM was subjected to either incuba- 
tion with CASPc only, or sole irradiation with 675-nm 
light (Table I). In the absence of light, exposure of 
normal ECM to CASPc resulted in no significant 
alteration of SMC and EC attachment, proliferation, 
or migration. Likewise, attachment, proliferation, 
Fig. 3. Plmtomicrograph of bovine aortic EC-ECM 
(original magnification, • Immunostaining with anti- 
fibronectin IgG (1:100) and fluorescein-labeled secondary 
antibody befbre (A) and after (B) PDT. Note that staining 
patterns and intensities before and after PDT do not differ. 
and migration of SMCs and ECs on matrixes irradi- 
ated with thcrmoneutral 675-nm light at a fluence of 
100 J /cm 2 was similar to untreated ECM. 
DISCUSSION 
ECs and the underlying SMCs are the primary cell 
types that comprise the vascular wall. If SMCs are 
completely eliminated by PDT early at the onset of 
IH, obstructing lesions most likely will not develop. 4 
PDT of  fully developed vascular stenoses, on the other 
hand, has not been found to significantly diminish 
luminal narrowing despite considerable c ll depletion 
in and beyond the obstructing lesionJ 7 These data 
appear to indicate that the effects of PDT are primarily 
based on cytotoxicity rather than on structural alter- 
ation ofECM. Although the ECM does not physically 
change aRer PDT, ~8 tbur consistent histologic find- 
ings have been reported that imply functional changes 
in the extracellular environment. First, after balloon 
injury and PDT no cells are present in the arterial 
media after 6 months, whereas the intimal surface is 
completely ined with normal-appearing endothelium 
by 2 weeks. 4Second, despite the presence of cellular 
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Fig. 4. Attachment, proliferation, and migration of bovine aortic SMCs (solid fill) and bovine 
aortic ECs (hatched fill) on normal ECM (Matrix), plain tissue-culture plastic (Plate), and 
PDT-treated ECM (PDT). Data are expressed as mean percentage + SEM and normalized for 
values obtained on normal ECM. *Statistically significant differences in which p < 0.05 when 
compared with "Matrix" for the respective cell type. ]'p < 0.05 when compared with "Plate" for 
ECs. 
Table I. SMC and EC functions on different reated matrixes 
Attachment Proliferation Migration 
SMC (n = 15) EC (n = 12) SMC (n = 15) EC (n = 15) SMC (n = 6) EC (n = 9) 
Control  95 + 0.4 86 + 0.6 |00  -+ 1.4 100 _+ 6.2 100 + 0.9 100 + 0.8 
Drug only 90 + 1.0 88 + 0.6 94 + 4.7 113 + 9.0 103 + 1.3 104 _+ 1.1 
Light only 95 + 1.4 88 +_ 0.6 99 _+ 4.9 102 _+ 1.6 96 + 1.4 105 + 1.2 
PDT 86 + 0.4* 88 + 0.6 46_+ 0.5 129 + 6.2* 40 + 1.0" 118 + 1.2" 
Data expressed as mean percentage _+ SEM. 
*p < 0.05 when compared with control group. 
debris in the vascular wall that is attributable to 
PDT-induced cytotoxicity,, TM no inflammatory reac- 
tion with infiltration of phagocytizing macrophages 
has been observedY 92~ Third, at the interface be- 
tween normal and PDT-treated vessel segments, 
where live cells such as ECs, SMCs, and fibroblasts 
remain present, there is no indication of an increased 
proliferative or migratory activity of SMCs. 4 Fourth, 
no thrombus formation has been noted after balloon 
injury of arteries and subsequent PDT 4Js' i l  except for 
one recently published article. 22 In summary, these 
in-vivo observations suggest that vascular PDT leaves 
behind an environment that favors expedient reen- 
dothelialization but inhibits SMC growth and subse- 
quent development of IH. It was therefore hypoth- 
esized that in addition to cell eradication, PDT may 
induce changes in the extracellular portion of the 
vascular wall. These changes may modulate the func- 
tion of repopulating ECs and SMCs. 
Cultured bovine vascular ECs produce an ECM 
that is similar in organization and macromolecular 
composition to the naturally occurring subendothe- 
lium. 2a This ECM does not function only as an inert 
structural support, but rather regulates attachment, 
proliferation, migration, and differentiation of cells. 24 
The effects on cell behavior are to a large extent 
ascribed to the native composition and three-dimen- 
sional structure of the ECM that induce a permissive 
change in the shape of cells and allow them to respond 
more readily to physiologically occurring hormones 
and growth f~ictors in serum and plasma, is In most 
cases, isolated single-matrix components failed, even 
when applied in various combinations, to elicit the 
biologic responses induced by a naturally produced 
ECM. 26 Because the in-vitro reconstitution of ECM 
f~om its isolated constituents into the correct, highly 
ordered structure that it represents would be a for- 
midable task, isolated ECM produced by bovine ECs 
was used in our study. 
Our results amply corroborate the importance of 
cell-derived ECM fbr SMC and EC function. In 
addition to structural constituents, EC-derived ECM 
is known to contain growth factors such as platelet- 
derived growth factor 27 and basic fibroblast growth 
factor TM that represent important mitogens for SMCs. 
It was therefore not surprising to find SMC prolifera- 
tion and migration increased on ECM as compared 
with tissue-culture plastic. Recently, other investiga- 
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tors have described radical changes in the functional 
character of vascular SMCs in vitro when isolated 
from normal ECM and cultured in a ECM-free 
environment, that is, as a monolayer on plastic. 28 
In contrast to this report, these experiments also 
authenticated diminished EC proliferation and mi- 
gration on normal ECM. The foundation of this 
behavior of ECs, however, is not clear. Conflicting 
findings that demonstrated increased SMC and EC 
growth on ECM when compared with plastic could 
possibly originate from different culture conditions 
(e.g., numbers of ceils seeded and cell passage) and 
experimental designs129 In this study the absence of 
exogenous growth factors and the use of serum-poor 
cell-culture media were thought to facilitate the 
identification of solely ECM-mediated effects. Par- 
ticular culture conditions are known to have profound 
consequences forthe cell growth and the composition 
of the deposited ECM.  29 Even the temporary absence 
or presence of ECM-associated EC growth stimula- 
tors, such as basic fibroblast growth factor, or EC- 
inhibitors, such as type V collagen, glycoproteins, 
glycosaminoglycans, ~ TGF [~,aLa2 and nitric oxide, "<~ 
can result in decreased EC growth. 
The existence of a broad variety of growth stimu- 
lators and inhibitors in conjunction with experimental 
data suggests redundancy ofthe different systems and 
also additive effects. 34"3s Because redundancy may 
limit the efficacy of antibodies to a single growth 
t)ctor to block cell attachment, proliferation, and 
migration, the use of novel treatment methods uch as 
PDT, which potentially targets multiple growth fac- 
tors, growth inhibitors, hormones, and matrix con- 
stituents at the same time, has theoretic appeal. 
PDT has primarily been used for its cytotoxic 
biologic effects and has therefore had its greatest 
development in the treatment of cancer. As PDT of 
neoplastic and other proliferative disorders uch as 
arthritis and IH progressed to clinical trials, new 
photosensitizers with fewer side effects have been 
developed and advocated. Compared with the tradi- 
tionally used hematoporphyrin derivative (HpD), 
which is currently under clinical evaluation to treat 
different cancers, second-generation photosensitizers 
such as CASPc have distinct advantages. They appear 
to have less dark toxicity than HpD in vitro and to 
generate greater cytotoxicity, but less systemic toxic- 
ity, in vivo than HpD. a6 Finally, these drugs are 
activated with longer light wavelengths--for ex- 
ample, 675-nm light for CASPc--that have a deeper 
tissue penetration depth than the 630-nm light used 
to activate HpD. 37 
When added in aqueous olutions, CASPc binds 
avidly to protein molecules. 3~ On illumination, frec 
radical moieties are generated that alter proteins. It is 
therefore conceivable that PDT may have also de- 
pleted other relevant, biologically active components 
in the ECM and subsequently caused altered EC and 
SMC function. These in vitro findings of differential 
cell modulation on isolated ECM support this hy- 
pothesis. 
When compared with untreated ECM, PDT 
treated ECM significantly compromised SMC attach- 
rnent, proliferation, and migration, and thereforc 
corresponds with the in vivo prevalence of a persis- 
tently acellular vessel media after PDT. Because SMC 
penetration through the media into the subendothe 
lium is instrumental for the development of intimal 
thickening, it can be reasoned that in addition to 
cytotoxicity, alteration of ECM may also represent a 
cornerstone of PDT-mediated prevention of IH. 
Interestingly, EC proliferation and migration 
were significantly potentiated after PDT of isolated 
ECM. To rule out the possibility that PDT physically 
removed the entire ECM in the culture dish, which 
might have explained the similarity of the changes 
seen with SMCs and ECs on PDT-treated matrixes 
versus ECM-free plates, immunostaining of ECM 
with a monoclonal antibody directed against fi- 
bronectin was perfbrmed both immediately befbre 
and after PDT (Fig. 3). The fluorcsccncc signal bcfore 
and aftcr PDT did not producc markcd diffcrcnccs, 
which implics that structurally comparablc matrixes 
were present before and after the treatment. This may 
also explain in part why the attachment of ECs to 
PDT-trcated ECM was unaffcctcd. In conjunction 
with diminished SMC attachment after PDT, it can be 
postulated that different cell-binding sites for ECs 
and SMCs on thc ECM werc differentially targctcd 
and inactivated by PDT. Despite the problcms with 
transferring in-vitro data to thc in-vivo situation, our 
study firmly suggcsts that rapid endothelialization f 
PDT-trcatcd vcsscl segments i  probably largely indc- 
pcndcnt from thc abscncc of SMCs. Convcrscly, 
inhibition of SMC ingrowth into the subendothelium 
may not be solely mediated by the presence of an EC 
monolayer. 
CONCLUSION 
This report establishes altered vascular cell func- 
tion caused by PDT-induced changes in the ECM, 
and opens a new line of investigation that may not 
only provide further insights into the mechanisms of
vascular PDT, but may also help to gain a better 
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unders tand ing  o f  the various interact ions between the 
cells and their immediate  env i ronment  in vascular 
remode l ing .  
We express our gratitude to Mabel Chang, Norman 
Michaud, and Hassan Albadawi for their excellent technical 
assistance, and to Dr. Thomas Flotte for many helpful 
discussions with regard to preparation and analysis of  the 
electron micrographs. The advice and continuing support 
of  Dr. R. Rox Anderson is highly appreciated. We also thank 
CIBA-Geigy for the gift of  CASPc. 
REFERENCES 
1. Davies MG. Pathobiology of intimal hyperplasia. Br J Surg 
1994;81:1254-69. 
2. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for 
restenosis based on cell biology: clues for the development of
new preventive therapies. J Am Coil Cardiol 1991; 17:758 -69. 
3. Clowes AW, Reidy MA. Prevention of stenosis after vascular 
reconstruction: pharmacologic control of intimal hyperpla- 
sia--a review. J VAsc SUrtG 1991;13:885-891. 
4. LaMuraglia GM, ChandraSekar NR, Flotte TJ, Abbott WM, 
Michaud N, Hasan T. Photodynamic therapy inhibition of 
experimental intimal hyperplasia: acute and chronic effects. 
J VASe SURG 1994;19:321-31. 
5. Dubbelman TMAR, Prinsze C, Penning LC, van Steveninck J. 
Photodynamic therapy: membrane and enzyme photobiology. 
In: Henderson BW, Dougherty TJ, editors. Photodynamic 
therapy: basic principles and clinical applications. New York: 
Marcel Dekker, Inc., 1992:37-46. 
6. HilfR. Cellular targets ofphotodynamic therapyas a guide to 
mechanisms. In: Henderson BW, Dougherty T], editors. 
Photodynamic therapy: basic principles and clinical applica- 
tions. New York: Marcel Dekker, Inc., 1992:47-54. 
7. LaMuraglia GM, Ortu P, Flotte TJ, et al. Chloroaluminum 
sulfonated phthalocyanine partitioning in normal and intimal 
hyperplastic artery in the rat: implications for photodynamic 
therapy. Am J Pathol 1993;142:1898-905. 
8. LaMuraglia GM, Klyachkin ML, Adili F, Abbott WM. Photo- 
dynamic therapy of vein grafts: suppression of intimal hyper- 
plasia of the vein graft but not the anastomosis. J VASe SURG 
1995;21:882-90. 
9. Schwartz RS, Koval TM, Edwards WD, et al. Effect of external 
beam irradiation on neointimal hyperplasia fter experimental 
coronary artery injury. ] Am Coil Cardiol 1992;19:1106-13. 
10. Neville R, Unger EF, Shou M, et al. Dose-dependent smooth 
muscle cell proliferation i duced by thermal injury with pulsed 
infrared lasers. Circulation 1992;86:1249-56. 
11. Phillips GRIII, Peer RM, Upson JF, Ricotta J]. Late compli- 
cations of revascularizafion for radiation-induced arterial dis- 
ease. J VAsc SURG 1992;16:921-5. 
12. Madri JA, Bell L, Marx M, Merwin JR, Basson C, Prinz C. 
Effects of soluble factors and extracellular matrix components 
on vascular cell behavior in vitro and in vivo: models of 
de-endothelialization and repair. J Cell Biochem 1991;45: 
123-30. 
13. Raghow R. The role ofextracellular matrix in postinflamma- 
tory wound healing and fibrosis. FASEB J 1994;8:823-31. 
14. GrfinwaldJ, Haudenschild CC. Intimal injury in vivo activates 
vascular smooth muscle cell migration and explant outgrowth 
in vitro. Arteriosclerosis 1984;4:183-8. 
15. Gajdusek CM, Carbon S. Injury-induced release of basic 
fibroblast growth fhctor from bovine aortic cndothclium. 
] Cell Physiol 1989;139:570-9. 
16. Hasson JE, Wiebe DH, Sharefldn ]B, Abbott WM. Migration 
of adult human vascular endothelial cells: effect ofextracellular 
matrix proteins. Surgery 1986;100:384-90. 
17. Hsiang YN, Crespo MT, To EC, Sobch MS, Greenwald SE, 
Bower RE). Preventing restenosis n atherosclerotic miniswine 
with photodynamic therapy. Proceedings of Society of Photo- 
optical Instrumentation E gineers (SPIE) 1995;2395:384-9. 
18. Ortu P, LaMuraglia GM, Roberts WG, Flotte T], Hasan T. 
Photodynamic therapy of arteries: anovel approach for treat- 
ment of intimal hyperplasia. Circulation 1992;85:1189-96. 
19. Grant WE, Speight PM, MacRobert AJ, Hopper C, Brown SG. 
Photodynamic therapy of normal rat arteries after photosen- 
sitisation using disulphonatcd aluminium phthalocyanine and 
5- aminolaevulinic a id. Br J Cancer 1994;70:72-8. 
20. Hsiang YN, Houston G, Crespo T, et al. Preventing intimal 
hyperplasia with photodynamic therapy using an intravascular 
probe. Ann Vase Surg 1995;9:80-6. 
21. Nyamekye I, Anglin S, McEwan J, Alexander M, Bown S, 
Bishop C. Photodynamic therapy of normal and balloon- 
injured rat carotid arteries using 5-amino-levulinic a id. Cir 
culation 1995;91:417-25. 
22. Eton D, Borhani M, Spero K, Cava R, Grossweiner L, Alan SS. 
Photodynamic therapy: cytotoxicity of aluminum phthalocya- 
nine in intimal hyperplasia. Arch Surg 1995;130:1098-103. 
23. Korncr G, Bjornsson TD, Vlodavsky I. Extraccllular matrix 
produced by cultured corneal and aortic endothelial cells 
contains active tissue-type and urokinase-type plasminogcn 
activators. J Cell Physiol 1993;154:456-63. 
24. Rogelj S, Klagsbrun M, Atzmon R, et al. Basic fibroblast 
growth factor is an extracellular matrix component required 
tbr supporting the proliferation of vascular endothelial cells 
and the differentiation of PC 12 cells. J Cell Biol 1989;109: 
823-31. 
25. Vlodavsky I, Folkman ], Sullivan R, et al. Endothelial 
cell-derived basic fibroblast growth factor: synthesis and 
deposition into subendothelial extracellular matrix. Proc Natl 
Acad Sci U S A 1987;84:2292-6. 
26. Fridman R, Alon Y, Doljanski F, Fuks Z, Vlodavski I. Cell 
interaction with the extracellular matrices produced by endo- 
thelial cells and fibroblasts. Exp Cell Res 1985;158:461-76. 
27. Kelly JL, Sanchez A, Brown GS, Chesterman CN, Sleigh MJ. 
Accumulation of PDGF B and cell-binding forms of PDGF A 
in the extracellular matrix. J Cell Biol 1993;121:1153-63. 
28. Casscells W, Lappi DA, Olwin BB, et al. Elimination ofsmooth 
muscle cells in experimental restenosis: targeting offibroblast 
growth factor eceptors. Proc Natl Acad Sci U S A 1992;89: 
7159-63. 
29. Gospodarowicz D, Vlodavsky I, Savion N. The extracellular 
matrix and the control of proliferation of vascular endothelial 
and vascular smooth muscle cells. Journal of Supramolecular 
Structure 1980;13:339-72. 
30. Davies MG. The vascular endothelium: a new horizon. Ann 
Surg 1993;218:593-609. 
31. SatoY, Rifldn DB. Inhibition ofendothelial cell movement by 
pericytes and smooth muscle cells: activation of a latent 
transforming growth factor-131-1ike molecule by plasmin dur- 
ing co-culture. J Cell Biol 1989;109:309-15. 
32. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-'Oja J. Human 
mast cell chymase and leukocyte lastase release latent rans- 
forming growth factor-Ill from the extracellular matrix of 
JOURNAL OF VASCULAR SURGERY 
Volume 23, Number 4 Adi l i  et al. 705 
cultured human epithelial and endothelial cells. Proc Natl 
Acad Sci U S A 1995;270:4689-96. 
33. Sarkar R, Webb C, Stanley JC. Nitric oxide inhibition of 
endothelial cell mitogenesis and proliferation. Surgery 1995; 
118:274-9. 
34. Thyberg J, Hedin U, Sj61und M, Palmberg L, Bottger BA. 
Regulation of differentiated properties and proliferation of 
arterial smooth muscle cells. Arteriosclerosis 1990;10:966-90. 
35. Reidy MA. Factors controlling smooth-muscle c ll prolifera- 
tion. Arch Pathol Lab Med 1992;116:1276-80. 
36. Koshida K, Hisazumi H, Komatsu K, Hirata A, Uchibayashi T.
Possible advantages of aluminum-chloro-tetrasulfi.~nated 
phthalocyanine over hematoporphyrin derivative as a photo- 
sensitizer in photodynamic therapy. Urol Res 1993;21:283-8. 
37. Cheong W, Prahl SA, Welch AJ. A review of the optical 
properties of biological tissues. IEEE J Quantum Electronics 
1990;26:2166-85. 
38. Rosenthal I. Phthalocyanines as photodynamic scnsitizers. 
Photochem Photobiol 1991;53:859-70. 
Submitted September 7, 1995; accepted December 5, 1995. 
